The Cell Therapy Commercialization Summit is the only event where business executives, along with clinical operations stakeholders, learn cutting-edge strategies towards production and commercialization of viable therapeutic products, enabling you to turn scientific business challenges into money-making solutions. Highlights of the Summit include:
Operational Strategies
• Identify Therapeutic Opportunities to Develop the Most Robust Pipelines.
• Manage Big Pharma Alliances To Ensure Effective Partnering of Cell Therapy Platforms
• Implement Your Partnership to Meet Pipeline Development Goals
• Determine What Pipelines Will Attract Investors in an Unstable Economy
• Ensure your Investments Have Enforceable Intellectual Property
• Outsourcing Your Clinical Trials to Minimize Cost and Streamline the Clinical Process
• Maintaining Quality & Maximizing Efficiencies in Post-Production Logistics
• Sail Through the Murky Waters of Reimbursement For Cell Therapies
Business Strategies
• Choose the Right Design Parameters for Trial Efficiency and Sustainability
• Minimize Waste, Maximize Efficiencies, and Speed Up Timelines During the Clinical Trial Transition
• Maintain the Quality of Cell Therapy Products and Ancillary Materials
• Overcome Cold Chain Inefficiencies to Deliver a Fully Potent, Commercially Viable Cell Therapy Product
• Identify and Establish Optimal Delivery Systems for Your Cell Therapy Product
• Running a Bioprocessing Mechanism that Will Give You a Viable Cost to Goods Model
Visit the Cell Therapy Commercialization Summit webpage.
Collocated alongside 5 industry events at the Clinical Business Expo, it is the one cell therapy conference where you will meet 200+ experts, 600+ attendees, 50+ exhibitors and have 10+ hours of incomparable networking time with invested peers in all areas of clinical development. Find out more about the Clinical Business Expo.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment